BWAY - BrainsWay Ltd.: The Winning Streak Continues (BWAY)
BrainsWay Ltd. (NASDAQ:BWAY) traded at a new 52-week high today of $12.42. Approximately 4.4 million shares have changed hands today, as compared to an average 30-day volume of 24,000 shares.
BrainsWay Ltd. (NASDAQ:BWAY) is currently priced 4.3% above its average consensus analyst price target of $8.74.
BrainsWay Ltd is a commercial-stage medical device company focused on advancing neuroscience to improve health and transform lives. It is engaged in the development and commercialization of noninvasive neurostimulation products using its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD), obsessive-compulsive disorder (OCD), and smoking addiction. It derives revenues from the lease and sale of Deep TMS systems.
BrainsWay Ltd. share prices have moved between a 52-week high of $11.77 and the current low of $5.13 and are currently at $9.13 per share.
Receive IBN Spotlights - "Bite Size" Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected
About IBN (InvestorBrandNetwork)
IBN consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and Code Editorial Syndication to 5,000+ broadcast outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign and the NEW normal.
For more information on IBN, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer